EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Failure of Autophagy in Pompe Disease

Hung Do iD, Naresh K Meena iD, Nina Raben

Biomolecules · 13.05.2024 · 14 (5) · 573

DOI: 10.3390/biom14050573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 13.05.2024. Verfasst von Hung Do und 2 weiteren Autor:innen. Beteiligte Einrichtung: M6P Therapeutics, 20 S. Sarah Street, St. Louis, MO 63108, USA. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Autophagy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy is an evolutionarily conserved lysosome-dependent degradation of cytoplasmic constituents. The system operates as a critical cellular pro-survival mechanism in response to nutrient deprivation and a variety of stress conditions. On top of that, autophagy is involved in maintaining cellular homeostasis through selective elimination of worn-out or damaged proteins and organelles. The autophagic pathway is largely responsible for the delivery of cytosolic glycogen to the lysosome where it is degraded to glucose via acid α-glucosidase. Although the physiological role of lysosomal glycogenolysis is not fully understood, its significance is highlighted by the manifestations of Pompe disease, which is caused by a deficiency of this lysosomal enzyme. Pompe disease is a severe lysosomal glycogen storage disorder that affects skeletal and cardiac muscles most. In this review, we discuss the basics of autophagy and describe its involvement in the pathogenesis of muscle damage in Pompe disease. Finally, we outline how autophagic pathology in the diseased muscles can be used as a tool to fast track the efficacy of therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IIAutophagyHumansAnimalsGlycogenLysosomesalpha-GlucosidasesMuscle, Skeletal

Stichwörter der Autor:innen

Pompe diseaseautophagyenzyme replacement therapyglycogen degradationlysosomemuscle

Substanzen

Glycogenalpha-Glucosidases

Autor:innen und Institutionen

  • M6P Therapeutics, 20 S. Sarah Street, St. Louis, MO 63108, USA.

ORCID-Profile: Hung Do, Naresh K Meena

Zitieren

APA

Do, H., Meena, N. K., & Raben, N. (2024). Failure of Autophagy in Pompe Disease. Biomolecules, 14(5), 573. https://doi.org/10.3390/biom14050573

Vancouver

Do H, Meena NK, Raben N. Failure of Autophagy in Pompe Disease. Biomolecules. 2024;14(5):573. doi:10.3390/biom14050573

BibTeX
@article{Do2024,
  author = {Do, Hung and Meena, Naresh K and Raben, Nina},
  title = {Failure of Autophagy in Pompe Disease},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {573},
  doi = {10.3390/biom14050573}
}
Kostenlos starten →